MedPath

Comparative study in management of Amavata with ashwagandadi guggulu and simhanada guggulu with erandamooladi kshara basti and valuka sweda

Phase 3
Conditions
Health Condition 1: 3- Administration
Registration Number
CTRI/2023/07/055127
Lead Sponsor
Dr Venkatesh R
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects who fulfil diagnostic criteria of Amavata & Rheumatoid arthritis, irrespective of gender, religion, occupation and socio-economic status.

Age group between 18-60years, fit for Basti and willing to sign informed consent.

Diagnosed cases of Rheumatoid arthritis, with or without conventional medication.

Exclusion Criteria

Subjects with other systemic diseases which would interfere the present study such as Diabetes mellitus, CAD,CKD.

Subjects who have developed other connective tissue disorders or any Autoimmune disorder such as Osteoarthritis, SLE, Gouty Arthritis.

Pregnant women and Lactating mother.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain management & improving quality of life <br/ ><br>Reduction in their <br/ ><br>ESR <br/ ><br>CRP levels <br/ ><br>Timepoint: 1 year <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To compare the efficacy of Ashwagandhadi Guggulu & Simhanada Guggulu along with Erandamooladikshara basti & Valuka Sweda in management of Amavata vis-à-vis Rheumatoid Arthritis <br/ ><br>To assess quality of life in subjectsTimepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath